NEW YORK (GenomeWeb) — Immunovia and the University of Liverpool have entered into a collaboration to validate Immunovia's proteomic blood test for early detection of pancreatic cancer in a prospective clinical study.

The study, which aims to validate Immunovia's Immray PanCan-d test, will start in the second half of 2016 and run for three years across sites in the US and Europe.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.